← Leaderboards
Brian K Adler
University Of Alabama At Birmingham
$380,041
Attributed
$380,041
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$380,041 · 1
By mechanism
M01$380,041 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert B. Diasio$27,640,960
- James O Hill$39,907,599
- Robert P Kimberly$63,455,986
- Keith H Nuechterlein$31,385,871
- Sten H Vermund$224,599,612
Others in their field
Top investigators on “Blood Disorder Chemotherapy”
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,248,845
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Adam L Boxer · Mayo Clinic Rochester$30,350,302
- Keith A. Johnson · Banner Health$30,350,302
- Timothy J Ley · Washington University$27,473,374
- Electra D. Paskett · Ohio State University$25,625,975
Research focus
Blood Disorder ChemotherapyBlood Vessel OcclusionClinical ResearchEthylene OxideHuman SubjectHuman Therapy EvaluationPathologic ProcessSickle Cell Anemia
Grant awards (3)
CRL 5861 (PURIFIED POLOXAMER 188) IN SICKLE CELL DISEASE &VASO OCCLUSIVE CRISIS$175,256
M01 · FY2002 · RR
CRL 5861 (PURIFIED POLOXAMER 188) IN SICKLE CELL DISEASE &VASO OCCLUSIVE CRISIS$175,256
M01 · FY2001 · RR
CRL 5861 (PURIFIED POLOXAMER 188) IN SICKLE CELL DISEASE &VASO OCCLUSIVE CRISIS$29,529
M01 · FY2000 · RR